Par Drugs and Chemicals Limited, founded in 1999 and based in Bhavnagar, Gujarat, specializes in the production of Active Pharma Ingredients (APIs) and fine chemicals. Transitioning to a public company in 2018, it operates two manufacturing facilities in Bhavnagar and Ankleshwar, with multiple production blocks certified by the food & drugs control administration. The company offers a diverse product portfolio of 12 APIs and 6 Fine Chemicals, serving both domestic and international markets across 16 countries. Key clients include Essential Drugs Company Ltd., Pfizer Ltd., and United Phosphorus Ltd. In 2019, it raised Rs 8.53 Crore through an IPO. A new manufacturing block was added in 2021, enhancing production capacity to approximately 9,700 MTPA, distributed across four blocks dedicated to APIs, Magnesium Hydroxide, and Fine Chemicals. This expansion allows Par Drugs and Chemicals to strengthen its market presence and cater to a broader client base.
